Skip to main navigation Skip to search Skip to main content

GSK: A Randomized, Double-Blind-Placebo-Controlled Study to Evaluate the Safety of 12-Weeks Dosing with GW856553(LoSmapimod) and its effects on Inflammatory Markers, Infarct Size and Cardiac Function in Subjects with Myocardial Infarction.

  • Zawin, Marlene (CoPI)
  • Gruberg, Luis (PI)
  • Jeremias, Allen (CoPI)
  • Poon, Michael (CoPI)

Project: Research

Project Details

StatusFinished
Effective start/end date01/28/1009/15/11

Funding

  • Duke University: $4,850.00